MetLife, Inc.
At today's price, MetLife, Inc. (MET) is priced for 17.5% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
MetLife is a global life and group insurer, led by Group Benefits (about 55% of the business) and Retirement and Income Solutions, executing a multi-year plan called New Frontier that targets double-digit adjusted EPS growth and a 15% to 17% adjusted return on equity. Q1 2026 delivered adjusted EPS of $2.42, up 23%, with adjusted ROE at 17%, the top of the range. What the standard models miss is the per-share machine. The company is buying back stock aggressively (the share count is shrinking a
Is MET overvalued? See what's priced in →
1,336 institutional managers reported holding MET in 13F filings for the quarter ended 2026-03-31. Together they hold about 73% of the company; the top 10 hold 42%. 82 opened new positions that quarter. Held by Vanguard Group, BlackRock, Dodge & Cox, among others. On the short side, 15.9M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (4.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MET has cut its share count 25.3% over the past five years, spending $15.53B on repurchases. It pays a dividend, and has for 14 years running, raised 13 years straight; the current rate is $2.25 a share annually. Cash returned over the past three years: $4.19B in dividends and $8.53B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MET over the trailing three years. Absence is a fact about the company, not a signal. 25 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MET's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-05 | +2.5% | -3.5% |
| 2023-11-03 | 0.0% | +11.6% |
| 2024-02-17 | +0.6% | +3.4% |
| 2024-05-03 | -1.2% | -1.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MET's latest 8-K filings: 2026-06-29 (items 7.01); 2026-06-22 (items 5.07); 2026-05-15 (items 8.01, 9.01); 2026-05-06 (items 2.02, 7.01, 8.01, 9.01); 2026-04-07 (items 7.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.